首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Isolation and characterization of alpha 1-antitrypsin in PAS-positive hepatic granules from rats with experimental alpha 1-antitrypsin deficiency.
【2h】

Isolation and characterization of alpha 1-antitrypsin in PAS-positive hepatic granules from rats with experimental alpha 1-antitrypsin deficiency.

机译:实验性α1-抗胰蛋白酶缺乏症大鼠PAS阳性肝颗粒中α1-抗胰蛋白酶的分离和鉴定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic galactosamine (GalNH2) administration in rats decreases plasma alpha 1-antitrypsin (AAT) levels to 10-50% of control levels and induces the formation of diastase-resistant, PAS-positive granules, which contain AAT in hepatocytes. This report describes the isolation and purification of hepatic granule AAT by three different methods: solubilization with guanidine hydrochloride followed by gel filtration on Bio-gel A5M, extraction with methylamine and 2-chloroethanol, and solubilization with sodium dodecyl sulfate (SDS) followed by preparative SDS-polyacrylamide gel electrophoresis. All three methods yield a single protein which precipitates with anti-rat plasma AAT antibody, and which has an apparent molecular weight of 45,000 daltons, in contrast to the molecular weight of plasma AAT, 50,000 daltons. Unlike plasma AAT, granule AAT contains no sialic acid, galactose, or fucose. Moreover, granule AAT contains a reduced amount of N-acetylglucosamine and an increased amount of mannose, compared with plasma AAT. The carbohydrate content of granule AAT varies with the isolation procedure used. Granule AAT is susceptible to cleavage by endoglucosaminidase H, which indicates the presence of high-mannose type oligosaccharides. Comparison of the molecular weight, carbohydrate composition, isoelectric point, and endoglucosaminidase H sensitivity of granule AAT isolated from rats with GalNH2-induced AAT deficiency with granule AAT from PiZ humans extends the list of similarities between experimental GalNH2-induced AAT deficiency in rats by and genetically determined AAT deficiency in humans.
机译:在大鼠中长期施用半乳糖胺(GalNH2),可将血浆α1-抗胰蛋白酶(AAT)含量降低至对照水平的10-50%,并诱导抗胰酶,PAS阳性的颗粒形成,该颗粒在肝细胞中含有AAT。本报告介绍了通过三种不同方法分离和纯化肝颗粒AAT的方法:先用盐酸胍溶解,然后在Bio-gel A5M上进行凝胶过滤,再用甲胺和2-氯乙醇萃取,再用十二烷基硫酸钠(SDS)溶解,然后制备SDS-聚丙烯酰胺凝胶电泳。所有三种方法均产生一种蛋白,该蛋白会与抗大鼠血浆AAT抗体一起沉淀,其表观分子量为45,000道尔顿,而血浆AAT的分子量为50,000道尔顿。与血浆AAT不同,AAT颗粒不含唾液酸,半乳糖或岩藻糖。而且,与血浆AAT相比,颗粒AAT包含减少量的N-乙酰氨基葡糖和增加量的甘露糖。 AAT颗粒的碳水化合物含量随所用的分离程序而异。颗粒AAT容易被内切氨基糖苷酶H裂解,这表明存在高甘露糖型寡糖。比较GalZ2诱导的AAT缺乏症大鼠的AAT颗粒与PiZ人的AAT的颗粒的分子量,碳水化合物组成,等电点和内切葡糖胺半乳糖苷酶H敏感性,通过和比较了实验性的GalNH2诱导的大鼠AAT缺乏之间的相似性。基因确定的人类AAT缺乏症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号